未找到相关数据
Real-world effectiveness of eribulin in heavily pretreated patients with metastatic breast cancer in China: A multicenter retrospective study.
被引：0
作者：
Zhao, Yannan
Xie, Ning
Li, Wei
Chen, Wenyan
Lv, Zheng
Zheng, Yabing
Sun, Tao
Liu, Jieqiong
Zhang, Jian
Hu, Shihui
Wang, Yajun
Gong, C. C.
Li, Yi
Xie, Yizhao
Ge, Rui
Xu, Fei
Wang, Biyun
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai, Peoples R China
[2] Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, Changsha, Peoples R China
[3] Jiangsu Prov Hosp, Nanchang, Jiangsu, Peoples R China
[4] Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangsu, Peoples R China
[5] First Hosp Jilin Univ, Jilin, Jilin, Peoples R China
[6] Zhejiang Canc Hosp, Hangzhou, Peoples R China
[7] China Med Univ, Canc Hosp, Shenyang, Liaoning, Peoples R China
[8] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Dept Gen Surg, Guangzhou, Peoples R China
[9] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[10] Fudan Univ, Huadong Hosp, Shanghai, Peoples R China
[11] Sun Yat Sen Univ, Canc Ctr, Dept Med Oncol, Guangzhou, Peoples R China
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e13057
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13057
引用
收藏
页数：4
相关论文